ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Argen X SE

Argen X SE (ARGX)

631.60
0.00
(0.00%)
마감 30 1월 1:30AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
631.60
매수가
628.20
매도가
645.00
거래량
0.00
0.00 일간 변동폭 0.00
322.50 52주 범위 658.00
market_cap
전일 종가
631.60
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
62,499
발행 주식
59,194,000
배당수익률
-
주가수익률
-126.71
주당순이익(EPS)
-4.98
매출
1.27B
순이익
-295.05M

Argen X SE 정보

섹터
Coml Physical, Biologcl Resh
산업
Coml Physical, Biologcl Resh
웹사이트
본부
Amsterdam, North Holland, Nld
설립됨
-
Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the 유로넥스트 (Euronext) with ticker ARGX. The last closing price for Argen X was 631.60 €. Over the last year, Argen X shares have traded in a share price range of 322.50 € to 658.00 €.

Argen X currently has 59,194,000 shares in issue. The market capitalisation of Argen X is 37.39 € billion. Argen X has a price to earnings ratio (PE ratio) of -126.71.

ARGX 최신 뉴스

argenx Highlights 2025 Strategic Priorities

Reported $2.2 billion in preliminary* full-year 2024 global product net sales, inclusive of $737 million in fourth quarter sales Pre-filled syringe FDA PDUFA on track for April 2025 to support...

argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 6, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy

VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx's VYVGART® and VYVDURA portfolio approved in Japan for three indications – first...

argenx to Present at Upcoming Investor Conferences

November 26, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for...

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

First and only NMPA-approved treatment for patients with CIDP in China  Second VYVGART Hytrulo indication approved in China  November 11, 2024 – 7:30am ET  Amsterdam, the Netherlands— argenx...

argenx to Participate at Upcoming Investor Conferences

November 5, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

$573 million in third quarter global net product sales CIDP global expansion on track, with decisions on approval under review in Japan, Europe, China, and Canada Management to host conference...

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

October 24, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
16.61.056625643.461354900626.80086703DE
433.65.61872909699598658593.666966633.68602266DE
128415.3396639883547.6658527.862499599.42996572DE
26172.637.603485838845965844859309540.29842296DE
52278.678.9235127479353658322.560776452.63164847DE
156399.6172.24137931232658227.864938388.27339544DE
260499.6378.48484848513265893.0573772307.78338115DE

ARGX - Frequently Asked Questions (FAQ)

What is the current Argen X share price?
The current share price of Argen X is 631.60 €
How many Argen X shares are in issue?
Argen X has 59,194,000 shares in issue
What is the market cap of Argen X?
The market capitalisation of Argen X is EUR 37.39B
What is the 1 year trading range for Argen X share price?
Argen X has traded in the range of 322.50 € to 658.00 € during the past year
What is the PE ratio of Argen X?
The price to earnings ratio of Argen X is -126.71
What is the cash to sales ratio of Argen X?
The cash to sales ratio of Argen X is 29.47
What is the reporting currency for Argen X?
Argen X reports financial results in USD
What is the latest annual turnover for Argen X?
The latest annual turnover of Argen X is USD 1.27B
What is the latest annual profit for Argen X?
The latest annual profit of Argen X is USD -295.05M
What is the registered address of Argen X?
The registered address for Argen X is LAARDERHOOGTWEG 25, AMSTERDAM, NORTH HOLLAND, 1101 EB
What is the Argen X website address?
The website address for Argen X is www.argenx.com
Which industry sector does Argen X operate in?
Argen X operates in the COML PHYSICAL, BIOLOGCL RESH sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
ron_66271 ron_66271 4 분 전
Thank for Supporting My Argument.

JPM didn’t have the money to cover Lehman’s ‘Market to Market’ of $17 Billion on September 14th.

Need more?

“BlackRock?”
Why…



Ron
JPM
Zorax Zorax 4 분 전
He's going to sell them shitface bibles.
Doc logic Doc logic 6 분 전
exwannabe,

Simply put: Crossover to an active substance instead of placebo required that the active substance being utilized in the crossover be measured against a comparable group being treated with anything other than a known active substance. Comparators had to be changed when SO
NWBO
ron_66271 ron_66271 15 분 전
CTS are in the Same Camp as Preferred Shares.

Securitized by Derivative Contracts.

You didn’t understand the Derivative Market Meltdown of 2008.

Lehman’s wasn’t the problem.
JPM was.



Ron
JPM
littlejohn littlejohn 20 분 전
Traders who played other big names for

Wednesday could start back in

here on the cheapies...

META and MSFT make a lot of money...

And can spend on Ai - R and D...

Seems a good money flow watch...

so we watch..
MSFT
hbhmb hbhmb 21 분 전
You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
AIAD
Wrangler1 Wrangler1 23 분 전
Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
WDLF
Golfnut3 Golfnut3 24 분 전
Thanks for the input...
ALYI
littlejohn littlejohn 31 분 전
Fine idea, put sellers on 28 turned bullish

on Wednesday with big volume...

https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

those are willing share buyers at 28

if they get exercised with a close on
SMCI
trader53 trader53 32 분 전
DPLS 0.0004 - Short Squeeze Soon!


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________


https://
DPLS MFI
Plato_ Plato_ 33 분 전
https://investorshub.advfn.com/uimage/uploads/2025/1/30/jkzcuLinkedIn.png
About us

VeeMost Technologies Inc. is your trusted partner in delivering innovative, customer-focused IT solutions designed to empower your business. As a minority-owned technology provider,
GDVM
blackcat blackcat 34 분 전
Pretty horrifying situation. Not something you'd think could happen- although it was night and it is a busy airport.
dinogreeves dinogreeves 38 분 전
SMCI after the report it will get to the right valuation with time.
SMCI
dinogreeves dinogreeves 39 분 전
DeepSeek is fake.
SMCI
toogoodfella toogoodfella 40 분 전
IF YOU THINK THE BALANCE SHEET IS WRONG, BE A WHISLE BLOWER
YOULL BECOME VERY FAMOUS

LEHNQ
trader53 trader53 41 분 전
DPLS 0.0004 - Point of Maximum Financial Opportunity


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________
DPLS MFI
fuagf fuagf 44 분 전
Just hearing of it now on our news. Terrible!!!
Susie924 Susie924 44 분 전
There wasn’t much to hear but there was definitely a gasp at one point.
Kool Aid Man Kool Aid Man 45 분 전
Shieldcom's only 'contact' is a mail drop at their registered agent's office --Corporation Trust Center in Delaware. 'In 2012, it was the registered agent address of at least 285,000 separate American and foreign businesses who operate or trade in the United States'
https://en.wikipedia.org/
MONI
jjmentat jjmentat 47 분 전
Did you try Ebay??????
You know what they say........If you can't get it on Ebay or Walmart.......you're out of luck.......LOL
Fredddddy Fredddddy 48 분 전
Yes. I had been waiting on a good spot. Unfortunately came down with stomach bug Tuesday. (Thank you children). So I’m just getting back to level. And I missed it. On side lines waiting for entry.
XMaster2023 XMaster2023 49 분 전
Approval Tomorrow? It’s time!
NWBO
blackcat blackcat 49 분 전
Thanks- for some reason it won't load. I'll try it on my other laptop later.
"Something went wrong. Try reloading".
Ray_137 Ray_137 53 분 전
April fool's day! Like tons of other predictions.
COOP

최근 히스토리

Delayed Upgrade Clock